Kymera Therapeutics Inc
NASDAQ:KYMR
Income Statement
Earnings Waterfall
Kymera Therapeutics Inc
Revenue
|
78.6m
USD
|
Operating Expenses
|
-244.1m
USD
|
Operating Income
|
-165.5m
USD
|
Other Expenses
|
18.6m
USD
|
Net Income
|
-147m
USD
|
Income Statement
Kymera Therapeutics Inc
Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||
Revenue |
34
N/A
|
46
+35%
|
65
+40%
|
70
+9%
|
73
+4%
|
64
-12%
|
57
-11%
|
46
-19%
|
47
+2%
|
47
0%
|
52
+11%
|
47
-9%
|
79
+68%
|
|
Operating Income | ||||||||||||||
Operating Expenses |
(80)
|
(80)
|
(123)
|
(150)
|
(173)
|
(188)
|
(197)
|
(203)
|
(208)
|
(216)
|
(224)
|
(232)
|
(244)
|
|
Selling, General & Administrative |
(18)
|
(18)
|
(26)
|
(30)
|
(36)
|
(41)
|
(44)
|
(44)
|
(44)
|
(46)
|
(49)
|
(52)
|
(55)
|
|
Research & Development |
(62)
|
(62)
|
(97)
|
(120)
|
(137)
|
(147)
|
(153)
|
(159)
|
(164)
|
(171)
|
(175)
|
(179)
|
(189)
|
|
Operating Income |
(46)
N/A
|
(34)
+27%
|
(59)
-73%
|
(79)
-35%
|
(101)
-27%
|
(124)
-24%
|
(140)
-13%
|
(157)
-12%
|
(161)
-3%
|
(170)
-5%
|
(172)
-2%
|
(185)
-7%
|
(166)
+10%
|
|
Pre-Tax Income | ||||||||||||||
Interest Income Expense |
1
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
6
|
11
|
15
|
17
|
19
|
|
Pre-Tax Income |
(46)
N/A
|
(34)
+26%
|
(58)
-73%
|
(79)
-35%
|
(100)
-27%
|
(124)
-24%
|
(139)
-13%
|
(154)
-10%
|
(155)
-1%
|
(159)
-3%
|
(158)
+1%
|
(167)
-6%
|
(147)
+12%
|
|
Net Income | ||||||||||||||
Income from Continuing Operations |
(46)
|
(34)
|
(58)
|
(79)
|
(100)
|
(124)
|
(139)
|
(154)
|
(155)
|
(159)
|
(158)
|
(167)
|
(147)
|
|
Net Income (Common) |
(55)
N/A
|
(34)
+38%
|
(58)
-73%
|
(79)
-35%
|
(100)
-27%
|
(124)
-24%
|
(139)
-13%
|
(154)
-10%
|
(155)
-1%
|
(159)
-3%
|
(158)
+1%
|
(167)
-6%
|
(147)
+12%
|
|
EPS (Diluted) |
-1.23
N/A
|
-0.76
+38%
|
-1.31
-72%
|
-1.55
-18%
|
-2.09
-35%
|
-2.39
-14%
|
-2.71
-13%
|
-2.82
-4%
|
-2.87
-2%
|
-2.73
+5%
|
-2.7
+1%
|
-2.87
-6%
|
-2.52
+12%
|